Replicate Bioscience
About:
Replicate Bioscience creates novel oncology treatments to prevent and reverse drug resistance through a self-replicating RNA platform.
Website: https://replicatebioscience.com/
Twitter/X: Replicate_Inc
Top Investors: Apple Tree Partners
Description:
Replicate Bioscience creates novel oncology treatments to prevent and reverse drug resistance through a self-replicating RNA platform called SynRGY. By deploying SynRGY technology, the company aims to design novel treatments that prevent the occurrence of drug resistance and create solutions that enhance the effectiveness of many immuno-oncology regimens.
$46M
$1M to $10M
San Diego, California, United States
2020-01-01
info(AT)replicatebioscience.com
Andrew Geall, Herbert Kim Lyerly, Nathaniel Wang, Zachary Hartman
11-50
2021-09-08
Private
© 2025 bioDAO.ai